Search Results
Research Funding
Frequently asked questions specific to the Data Production FOA (RFA-HG-21-029, RFA-HG-21-030 and RFA-HG-21-031) discussed during the MorPhiC pre-application webinar.
… Your rationale for prioritization should reflect how your choices will contribute to that aspect of “generalizability.” … assayed; etc. Applicants should consider and justify their choices in making these tradeoffs. We anticipate that … where they are well-justified. Please justify your choices in context with rest of FOA. Does the program …
Event
The Genomics and Health Disparities Lecture Series was formed to enhance opportunities for dialogue about how innovations in genomics research and technology can impact health disparities. Topics will range from basic science to translational research.
… Disparities) and the Office of Minority Health at the Food and Drug Administration. Request an Accommodation … …
The Genomics Landscape
In the June 2024 issue of The Genomics Landscape, NHGRI Director Eric Green recognizes the 2023 recipients of the Bettie J. Graham Leadership Award for Enhancing DEIA in the Genomics Workforce.
… or misfolded proteins. These processes are essential for healthy development and aging and for cellular responses to …
Event
We invite scholars to submit ideas to be one of six to seven speakers at our symposium, “Irreducible Subjects: Disability and Genomics in the Past, Present, and Future”, with an additional opportunity to join a collected set of papers on the same theme.
… with disabilities. Improved education, better-informed choices about care, and life-saving therapeutics have led to …
News Release
A study published NIH researchers revealed that about half of individuals who said they don’t want to receive secondary genomic findings changed their mind after their healthcare provider gave them more detailed information.
… means that we should be skeptical about whether checkbox choices are accurately capturing people’s preferences.” Based …
For Patients and Families
Genetic tests may be used to identify increased risks of health problems, to choose treatments, or to assess responses to treatments.
… ill. The results of a diagnostic test may help you make choices about how to treat or manage your health. Predictive … and this information can also help people to make informed choices about their future, such as whether to have a baby. …
For Health Professionals
The ISCC-PEG Pharmacogenomics (PGx) Project Group has developed peer-reviewed online education for healthcare practitioners to advance pharmacogenomics in clinical practice.
… about evidence-based pharmacogenomic resources from the Food and Drug Administration (FDA), the Clinical …
Research at NHGRI
CRGGH uses genomic tools to understand the pathobiology of metabolic disorders, including obesity, hypertension, diabetes, dyslipidemia, and kidney disease.
… forces such as pathogens, climate, and ancient food scarcity have shaped human genomes and how these genomic … and lipid biomarkers mediate the metabolically healthy obesity phenotype: A shotgun proteomics Study. …
News Release
The U.S. National Institutes of Health (NIH) has long invested in basic genetics and genomics research, clinical trials, as well as translational medicine and social science studies, to advance our understanding of this widespread illness to help develop effective therapies.
… Today, the U.S. Food and Drug Administration (FDA) approved two gene …